BACE1 inhibitor drugs in clinical trials for Alzheimer's disease
R Vassar - Alzheimer's research & therapy, 2014 - Springer
Abstract β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the β-secretase
enzyme required for the production of the neurotoxic β-amyloid (Aβ) peptide that is widely …
enzyme required for the production of the neurotoxic β-amyloid (Aβ) peptide that is widely …
The role of ADAM10 in Alzheimer's disease
XZ Yuan, S Sun, CC Tan, JT Yu… - Journal of Alzheimer's …, 2017 - content.iospress.com
As a member of the A Disintegrin And Metalloproteinase (ADAM) family, ADAM10 has been
identified as the constitutive α-secretase in the process of amyloid-β protein precursor …
identified as the constitutive α-secretase in the process of amyloid-β protein precursor …
Alzheimer's disease mechanisms and emerging roads to novel therapeutics
C Sala Frigerio, B De Strooper - Annual review of neuroscience, 2016 - annualreviews.org
Ten years of remarkable progress in understanding the fundamental biochemistry of
Alzheimer's disease have been followed by ten years of remarkable and increasing clinical …
Alzheimer's disease have been followed by ten years of remarkable and increasing clinical …
Aducanumab and its effects on tau pathology: is this the turning point of amyloid hypothesis?
S Silvestro, A Valeri, E Mazzon - International Journal of Molecular …, 2022 - mdpi.com
Alzheimer's disease (AD) is a neurodegenerative disorder affecting millions of people
around the world. The two main pathological mechanisms underlying the disease are beta …
around the world. The two main pathological mechanisms underlying the disease are beta …
Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease
CEH Moussa - Expert opinion on investigational drugs, 2017 - Taylor & Francis
Introduction: BACE 1 is a protease that cleaves the transmembrane amyloid precursor
protein and generates amyloid-β peptides that accumulate in AD brains. No known …
protein and generates amyloid-β peptides that accumulate in AD brains. No known …
Low dose brain irradiation reduces amyloid-β and tau in 3xTg-AD mice
GD Wilson, TG Wilson, A Hanna… - Journal of …, 2020 - content.iospress.com
We have previously reported that low doses of external beam ionizing irradiation reduced
amyloid-ß (Aß) plaques and improved cognition in APP/PS1 mice. In this study we …
amyloid-ß (Aß) plaques and improved cognition in APP/PS1 mice. In this study we …
Alzheimer's therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies
M Ohno - Brain research bulletin, 2016 - Elsevier
Accumulating evidence points to the amyloid-β (Aβ) peptide as the culprit in the
pathogenesis of Alzheimer's disease (AD). β-Site amyloid precursor protein (APP)-cleaving …
pathogenesis of Alzheimer's disease (AD). β-Site amyloid precursor protein (APP)-cleaving …
Multifunctional effect of human serum albumin reduces Alzheimer's disease related pathologies in the 3xTg mouse model
A Ezra, I Rabinovich-Nikitin… - Journal of …, 2016 - content.iospress.com
Abstract Alzheimer's disease (AD), the prevalent dementia in the elderly, involves many
related and interdependent pathologies that manifests simultaneously, eventually leading to …
related and interdependent pathologies that manifests simultaneously, eventually leading to …
[HTML][HTML] Antioxidant and anti-Alzheimer activities of Clivia miniata (Lindl) roots, bulbs, and aerial parts: In-vitro and in-silico studies
AS ElNagar, MM Mohyeldin, NM Mostafa… - Biomedicine & …, 2023 - Elsevier
Clivia miniata (Lindl) is a member of the family Amaryllidaceae known for its chemically
diverse alkaloids with a wide range of biological activities. Many reports revealed a direct …
diverse alkaloids with a wide range of biological activities. Many reports revealed a direct …
Mutant SOD1 increases APP expression and phosphorylation in cellular and animal models of ALS
P Rabinovich-Toidman, I Rabinovich-Nikitin, A Ezra… - PLoS …, 2015 - journals.plos.org
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease and it is the most
common adult onset neurodegenerative disorder affecting motor neurons. There is currently …
common adult onset neurodegenerative disorder affecting motor neurons. There is currently …